|
7RNS
nSH2 domain of p85-alpha subunit of phosphatidylinositol 3-kinase in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;292 K;0.05 M cadmium sulfate hydrate, 0.1 M HEPES, pH 7.5, 1.0 M sodium acetate trihydrate
|
Resolution 1.14 Å
R-free 0.147
|
|
7RNU
nSH2 domain of p85-beta subunit of phosphatidylinositol 3-kinase in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;25% w/v PEG1500, 100 mM MIB, pH 5.0
|
Resolution 1.45 Å
R-free 0.222
|
|
7RNU
nSH2 domain of p85-beta subunit of phosphatidylinositol 3-kinase in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;25% w/v PEG1500, 100 mM MIB, pH 5.0
|
Resolution 1.45 Å
R-free 0.222
|
|
7RNU
nSH2 domain of p85-beta subunit of phosphatidylinositol 3-kinase in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;25% w/v PEG1500, 100 mM MIB, pH 5.0
|
Resolution 1.45 Å
R-free 0.222
|
|
7RNU
nSH2 domain of p85-beta subunit of phosphatidylinositol 3-kinase in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;292 K;25% w/v PEG1500, 100 mM MIB, pH 5.0
|
Resolution 1.45 Å
R-free 0.222
|
|
7RNV
SH2 domain of guanine nucleotide exchange factor Vav2 in complex with an actin peptide with phosphorylated tyrosine 53
Deposited 2021-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
52–60(9 aa)
Fragment:UNP residues 52-60
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;292 K;0.2 M sodium acetate trihydrate, 0.1 M Tris hydrochloride, pH 8.5, 30% PEG4000
|
Resolution 2.15 Å
R-free 0.272
|
|
9DUV
Cryo-EM structure of recombinant R254H ACTA1 phalloidin-stabilized F-actin
Deposited 2024-10-04
|
Different mutation/modification
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 13
PDB declaration: tridecameric
|
Chain A
3–377(375 aa)
Chain B
3–377(375 aa)
Chain C
3–377(375 aa)
Chain D
3–377(375 aa)
Chain E
3–377(375 aa)
Chain F
3–377(375 aa)
|
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:R254H
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ADP ADENOSINE-5'-DIPHOSPHATE × 6
MG MAGNESIUM ION × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7;25 mM KCl, 2 mM EGTA, 60 mM MOPS (pH7), 1 mM DTT, and 4 mM MgCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|